
Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistant to remdesivir, according to researchers at NYU Grossman School of Medicine and… read on > read on >